According to Nakauma-González et al. [32], DSC2 and DSG2 in bladder cancer are markers of intratumoral genomic and immunologic heterogeneity, particularly evident through squamous differentiation. This evidence concerns the gene DSC2 and urinary bladder carcinoma.